Lakefront Biotherapeutics NV
GLPGF LKFTCIK 0001421876 · Pharmaceutical Preparations · Nasdaq, OTC
- GALAPAGOS NV (until 2026-05-06)
Revenue (TTM)
€1.11B
+303.5% YoY
FY Dec 2025
Net Income (TTM)
€320.88M
+333.1% YoY
FY Dec 2025
EPS Diluted (TTM)
€4.87
+334.8% YoY
FY Dec 2025
Gross Margin
97.3%
FY Dec 2025
Operating Margin
26.5%
FY Dec 2025
Net Margin
28.9%
FY Dec 2025
Free Cash Flow (TTM)
—
FY Dec 2025
Cash
€40M
FY Dec 2025
Total Debt
—
FY Dec 2025
Shares Outstanding
65.9M sh
FY Dec 2025